Franca Ferraraccio Selected Research

Atherosclerotic Plaque (Atheroma)

3/2024	Microplastics and Nanoplastics in Atheromas and Cardiovascular Events.
1/2023	Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque.
12/2021	Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment.
2/2017	Incretin treatment and atherosclerotic plaque stability: Role of adiponectin/APPL1 signaling pathway.
4/2015	Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment.
4/2011	Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism.
4/2008	Proteasome activity as a target of hormone replacement therapy-dependent plaque stabilization in postmenopausal women.
4/2007	Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity.
6/2006	Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Franca Ferraraccio Research Topics

Disease

14	Inflammation (Inflammations) 12/2023 - 06/2003
9	Atherosclerotic Plaque (Atheroma) 03/2024 - 06/2006
7	Myocardial Infarction 12/2021 - 04/2009
4	Carotid Stenosis (Carotid Artery Stenosis) 03/2024 - 04/2007
4	Atherosclerosis 02/2017 - 04/2007
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 10/2007
3	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2012
3	Neuralgia (Stump Neuralgia) 02/2021 - 02/2007
3	Hyperalgesia 02/2021 - 02/2007
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2024 - 01/2019
2	Edema (Dropsy) 12/2023 - 04/2003
2	Neoplasms (Cancer) 11/2022 - 05/2006
2	Keratitis 02/2021 - 11/2020
2	Fibrosis (Cirrhosis) 01/2019 - 06/2003
2	Insulin Resistance 01/2018 - 10/2007
2	Infarction (Infarctions) 03/2012 - 04/2009
2	Myocardial Ischemia (Ischemic Heart Diseases) 02/2012 - 11/2009
2	Rupture 04/2008 - 04/2007
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2024
1	Carotid Artery Diseases 03/2024
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024
1	Pain (Aches) 12/2023
1	Breast Neoplasms (Breast Cancer) 11/2022
1	Microsatellite Instability 04/2022
1	Stomach Neoplasms (Stomach Cancer) 04/2022
1	Colorectal Neoplasms (Colorectal Cancer) 04/2022
1	Transient Ischemic Attack 12/2021
1	Cytokine Release Syndrome 02/2021
1	Chronic Disease (Chronic Diseases) 02/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2021
1	Corneal Injuries 11/2020
1	ST Elevation Myocardial Infarction 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Hyperglycemia 01/2020
1	Overweight 01/2018

Drug/Important Bio-Agent (IBA)

6	UbiquitinIBA 11/2009 - 06/2006
6	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2009 - 06/2006
4	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2017 - 03/2010
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2017 - 04/2009
3	CytokinesIBA 12/2023 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2007
3	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 03/2012
3	Metformin (Glucophage)FDA LinkGeneric 10/2021 - 01/2018
3	NF-kappa B (NF-kB)IBA 02/2021 - 04/2008
3	IncretinsIBA 02/2017 - 01/2012
2	Formaldehyde (Formol)FDA Link 12/2023 - 02/2021
2	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2019
2	CollagenIBA 12/2021 - 04/2015
2	omega-Chloroacetophenone (Mace)IBA 12/2021 - 07/2021
2	SirtuinsIBA 07/2021 - 04/2015
2	LipidsIBA 11/2020 - 11/2009
2	Sirtuin 1IBA 01/2020 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2019 - 02/2007
2	Insulin (Novolin)FDA Link 01/2018 - 03/2012
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 02/2017 - 01/2012
2	Streptozocin (Streptozotocin)FDA Link 02/2012 - 11/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 05/2006
2	3-nitrotyrosineIBA 11/2009 - 04/2009
1	MelanocortinsIBA 03/2024
1	Polyethylene (Polythene)IBA 03/2024
1	Polyvinyl Chloride (PVC)IBA 03/2024
1	MicroplasticsIBA 03/2024
1	purineIBA 01/2024
1	Thioguanine (Tioguanine)FDA Link 01/2024
1	Snake Venoms (Snake Venom)IBA 12/2023
1	C-Type Lectins (C-Type Lectin)IBA 12/2023
1	IntegrinsIBA 12/2023
1	Cell Adhesion MoleculesIBA 12/2023
1	PCSK9 InhibitorsIBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	Estrogen ReceptorsIBA 11/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2022
1	Immune Checkpoint InhibitorsIBA 04/2022
1	SodiumIBA 12/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2021
1	LeptinIBA 07/2021
1	Sodium-Glucose Transport ProteinsIBA 07/2021
1	Prostaglandins AIBA 02/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2021
1	Glucosamine (Dona)IBA 02/2021
1	GlycolipidsIBA 02/2021
1	Lipid AIBA 02/2021
1	MonosaccharidesIBA 02/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2021
1	LipopolysaccharidesIBA 11/2020
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 11/2020
1	resolvin D1IBA 11/2020
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Retinaldehyde (Retinal)IBA 01/2019
1	Superoxide DismutaseIBA 01/2019
1	VimentinIBA 02/2017
1	AdiponectinIBA 02/2017

Therapy/Procedure

6	Therapeutics 12/2021 - 03/2008
5	Carotid Endarterectomy 03/2024 - 04/2007
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 07/2021 - 11/2009
2	Glycemic Control 03/2012 - 04/2009
1	Subcutaneous Injections 12/2023
1	Endarterectomy (Thromboendarterectomy) 12/2021
1	Percutaneous Coronary Intervention 01/2020